Home
NICE Guidance
Published Guidance

Erlotinib for the treatment of non-small-cell lung cancer

Technology appraisal guidance [TA162] Published: 26 November 2008 Last updated: 01 December 2012

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 374.